Faron Pharmaceuticals Oy (DI) (FARN) RNS Announcements

Add to Alert list
Date Time Source Announcement
07 Dec 2023 07:00 AM
RNS
MATINS Trial in Cell Reports Medicine
04 Dec 2023 07:00 AM
RNS
Grant of options
06 Nov 2023 08:13 AM
RNS
Faron Initiates Phase 2 Part of BEXMAB Study
06 Nov 2023 07:00 AM
RNS
Faron Initiates Phase 2 Part of BEXMAB Study
02 Nov 2023 01:00 PM
RNS
Faron to present data from BEXMAB study at ASH
27 Oct 2023 01:00 PM
RNS
Manager's transactions
27 Oct 2023 07:15 AM
RNS
Exercise of options
27 Oct 2023 07:00 AM
RNS
Results of Placing
26 Oct 2023 04:30 PM
RNS
Proposed Issue and Placing
11 Oct 2023 07:00 AM
RNS
Faron Announces Positive BEXMAB Study Update
03 Oct 2023 07:00 AM
RNS
Faron to host webcast on new BEXMAB study data
22 Sep 2023 04:00 PM
RNS
Board Changes
22 Sep 2023 11:00 AM
RNS
Results of EGM
21 Sep 2023 07:00 AM
RNS
Faron Appoints Interim Chief Medical Officer
08 Sep 2023 07:00 AM
RNS
Change in the Board of Directors
06 Sep 2023 07:00 AM
RNS
Faron to Present at H.C. Wainwright Conference
01 Sep 2023 10:00 AM
RNS
Notice of EGM
31 Aug 2023 02:00 PM
RNS
Exercise of options
29 Aug 2023 07:01 AM
RNS
Faron 2023 Half-Year Financial Results
29 Aug 2023 07:00 AM
RNS
FDA Orphan Drug Designation for Bexmarilimab
04 Aug 2023 07:00 AM
RNS
Notice of Half-Year Financial Results
02 Aug 2023 07:00 AM
RNS
Faron to Participate at Canaccord Conference
25 Jul 2023 07:00 AM
RNS
Grant of Options
19 Jul 2023 07:01 AM
RNS
Faron to Hold BEXMAB Study Conference Call
19 Jul 2023 07:00 AM
RNS
BEXMAB study update
30 Jun 2023 04:52 PM
RNS
Holding(s) in Company
29 Jun 2023 07:00 AM
RNS
Announcement of Placing
12 Jun 2023 07:00 AM
RNS
Exercise of options
09 Jun 2023 08:00 AM
RNS
New biomarker data from BEXMAB study at EHA2023
05 Jun 2023 07:00 AM
RNS
Board Member to Assume Transactional Advisor Role
24 Apr 2023 07:00 AM
RNS
Bexmarilimab Efficacy and Safety in MATINS Trial
24 Apr 2023 07:00 AM
RNS
Bexmarilimab Efficacy and Safety in MATINS Trial
19 Apr 2023 07:00 AM
RNS
Bexmarilimab KOL Event
18 Apr 2023 07:00 AM
RNS
Poster Presentations at AACR 2023
17 Apr 2023 07:00 AM
RNS
BEXMAB study update
13 Apr 2023 04:30 PM
RNS
Faron at Canaccord Oncology Virtual Conference
29 Mar 2023 07:00 AM
RNS
Appointment of Chief Financial Officer
24 Mar 2023 01:35 PM
RNS
Board Change
24 Mar 2023 01:30 PM
RNS
Results of AGM
22 Mar 2023 07:00 AM
RNS
Positive FDA Feedback to Progress Bexmarilimab
03 Mar 2023 09:00 AM
RNS
Notice of Faron Pharmaceuticals Ltd's AGM
03 Mar 2023 07:15 AM
RNS
Faron´s Annual Report 2022 Published
03 Mar 2023 07:00 AM
RNS
Financial Statement January 1 to December 31 2022
06 Feb 2023 06:00 PM
RNS
Update to Faron's Financial Calendar for 2023
06 Feb 2023 07:00 AM
RNS
Notice of 2022 Full-Year Results and Annual Report
01 Feb 2023 03:45 PM
RNS
Holding(s) in Company
27 Jan 2023 05:45 PM
RNS
Holding(s) in Company
27 Jan 2023 07:00 AM
RNS
Results of Placing
26 Jan 2023 04:30 PM
RNS
Proposed Issue and Placing
16 Jan 2023 11:00 AM
RNS
Price Monitoring Extension
UK 100

Latest directors dealings